Drug Design for Global Health

An AI-powered molecule design platform for global health researchers.
with funding support from

Drug Design for Global Health (dd4gh) is an AI-powered drug discovery platform developed by Medicines for Malaria Venture (MMV) and deepmirror. It aims to enable scientists working on diseases such as malaria, tuberculosis and neglected tropical diseases to design and evaluate new molecules using advanced AI tools.

Built with global health researchers and funded in part by the Gates Foundation, dd4gh helps scientists accelerate the discovery of new treatments for diseases that disproportionately affect low- and middle-income countries.

Apply for accessLoginRead FAQ

Accelerating drug discovery 
for global health

Drug discovery for diseases affecting low- and middle-income countries often faces significant resource constraints. At the same time, artificial intelligence is transforming how scientists design and evaluate potential medicines.

Drug Design for Global Health (dd4gh) helps bridge this gap.

The platform provides researchers with access to advanced AI tools that can generate new molecule designs, analyse large datasets and predict which compounds are most promising to test in the laboratory. By focusing experimental work on the most promising candidates, dd4gh has the potential to shorten research timelines and reduce costs for discovering treatments for diseases that pose significant global health challenges.dd4gh, supported by MMV and the Gates Foundation, makes these capabilities accessible and free of charge to researchers working on global health challenges worldwide.

Key Capabilities

Active learning workflows

The platform continuously improves predictions by learning from new experimental data as they become available.

Accessible web-based platform

Use advanced AI tools through an intuitive interface without needing specialised machine learning expertise.

Pre-trained global health models

Models trained on curated datasets from MMV allow researchers to begin exploring molecule design even before generating their own data.

AI-powered molecule design

Generate and evaluate new compound ideas using machine learning models trained on global health datasets.

Built with the global health research community

dd4gh was developed in collaboration with global health researchers through co-creation workshops in Ghana and Switzerland.
These workshops brought together medicinal chemists, computational chemists and drug discovery scientists working on diseases that disproportionately affect populations in low- and middle-income countries. Their input helped shape the platform to ensure it meets the practical needs of researchers working in global health.
“We’re aware of AI tools that can help with drug discovery, but being in a resource-limited setting makes purchasing a license cost prohibitive. Making dd4gh open access for researchers in global health means more of us can explore new ideas and apply AI to finding treatments for diseases that are part of our everyday realities.”
Caroline Maina
PhD Candidate, University of Cape Town

A collaboration for global health

Drug Design for Global Health is a partnership between Medicines for Malaria Venture (MMV) and deepmirror.

MMV contributes global health datasets and medicinal chemistry expertise in malaria and neglected disease drug discovery, while deepmirror provides the artificial intelligence and machine learning platform that powers dd4gh. The initiative is supported in part by funding from the Gates Foundation.

‍Together, the partners aim to expand access to advanced computational tools and help researchers accelerate the discovery of new treatments for diseases affecting vulnerable populations.

Get started now
Apply for AccessLogin

Who can access dd4gh?

dd4gh licenses are available free of charge to eligible researchers working on global health challenges. The platform development and licenses are funded by Medicines for Malaria Venture with support from the Gates Foundation.
‍
‍To qualify, you must:
Be involved in compound design for drug discovery (for example as a medicinal chemist or computational chemist).
Be working on diseases relevant to global health, such as malaria, tuberculosis, or neglected tropical diseases.
Use the platform for non-commercial research.

Apply for a dd4gh license

By applying, you confirm you meet the eligibility criteria above, have read the FAQs and agree to the terms of use: dd4gh.ai/terms-of-use‍

The onboarding process includes a short virtual introduction to the platform provided by the deepmirror team.

Apply for AccessTerms of use

Frequently Asked Questions

dd4gh is an AI-powered platform designed for researchers involved in drug discovery for global health. It helps scientists generate molecule designs, analyse datasets and predict which compounds are most promising to test in the laboratory.
The platform is intended for researchers working on diseases such as malaria, tuberculosis and neglected tropical diseases.

Licenses are granted to individual researchers rather than organisations. Applicants must be working on diseases relevant to global health and must use the platform for non-commercial research.

Yes. Once your application is approved, you will receive an email inviting you to dd4gh and to schedule an optional virtual onboarding session with the deepmirror team. Additional demo materials and tutorials are also available online.

Licenses are free for eligible researchers. The platform is funded by Medicines for Malaria Venture with support from the Gates Foundation.

Yes. Data uploaded to the platform remains private and is not shared with other researchers. When using dd4gh, users agree to the platform’s terms of use, including the privacy policy and data use guidelines.

Researchers are encouraged to acknowledge the use of dd4gh in the methods section of peer-reviewed publications or in the methods or sources section of presentations where results generated using the platform are reported.

If you meet the eligibility criteria and have reviewed the FAQs, you can request access by completing the application form below.

Please send any questions or enquiries to